Published 9 Jul 2019
Aggregates and particles in therapeutic protein products: causes, characterization and control
Written in collaboration with Judy Hadley, Malvern Panalytical’s Market Development Specialist – RMM Numerous studies have been undertaken to understand whether aggregates can cause immunogenicity (the ability of a protein or chemical substance to provoke an immune response) since uncertainty…READ MORE >
Tags: immunogenicity, John Carpenter, NTA, protein aggregates, RMM